{rfName}
So

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Goicoechea García CCorresponding AuthorMartínez-García MáAuthorPascual Serrano DAuthorSánchez-Robles EmAuthor
Share
Publications
>
Article

Some preclinical results of cannabinoids and pain [Resultados preclínicos de cannabinoides y dolor (algunos)]

Publicated to:Revista De La Sociedad Espanola Del Dolor. 29 3-9 - 2022-01-01 29(), DOI: 10.20986/resed.2022.4033/2022

Authors: Goicoechea García C; Sanz González M; Martínez-García MÁ; Pascual Serrano D; Sánchez-Robles EM

Affiliations

Área de Farmacología, Departamento de Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Unidad Asociada CSIC-IQM, Alcorcón, Spain - Author

Abstract

The role of the endocannabinoid system in the modulation of nociception and in the interpretation of those signals in known since the middle of the last century. The work carried out since then has made possible to better understand mechanisms of action involved and to synthesize different drugs able to modulate these signals. These drugs can be agonists, aimed at directly activating cannabinoid receptors, or substances that modulate the enzymes responsible for the synthesis and degradation of endocannabinoids. Pharmacologically, other substances present in the Cannabis sativa plant are also being studied, as well as synthetic derivatives obtained from these, which can bind, in addition to the aforementioned receptors, to other types of receptors involved in the physiology of the nociception. Results obtained to date demonstrate efficacy in multiple animal models of pain, both acute and chronic, both nociceptive and neuropathic, and offer new of research lines for the pharmacological treatment of chronic pain. © 2022 Ediciones Doyma, S.L.. All rights reserved.

Keywords
AnalgesiaArticleCannabinoidCannabinoid receptorCannabinoidsCannabis sativaChronic painDrug degradationDrug efficacyDrug synthesisMouseNociceptionNonhumanPharmacologyPreclinicPreclinical studyRat

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Revista De La Sociedad Espanola Del Dolor, Q4 Agency Scopus (SJR), its regional focus and specialization in Anesthesiology and Pain Medicine, give it significant recognition in a specific niche of scientific knowledge at an international level.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-15:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 17 (PlumX).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Goicoechea García, Carlos) and Last Author (Sánchez Robles, Eva María).

the author responsible for correspondence tasks has been Goicoechea García, Carlos.